Author

K. Suyama

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:scRNA-seq· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. T. Fard· 1 shared D. Kawauchi· 1 shared H. Liang· 1 shared I. Hasegawa· 1 shared J. C. Mar· 1 shared K. Ichijo· 1 shared K. Ji· 1 shared K. Kaibuchi· 1 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. T. Fard

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Meis1 isoform diversity orchestrates neural progenitor differentiation by regulating ATOH1 degradation at distinct subcellular compartments

T. Owa, T. Adachi, R. Shiraishi, K. Ichijo, K. Ji, M. Mizuno, K. Suyama, K. Nishitani, I. Hasegawa, M. Sone, D. Kawauchi, T. Nishioka, S. Taya, Y. Suzuki, K. Kaibuchi, , M. Hoshino

The paper identifies functionally antagonistic Meis1 isoforms that regulate ATOH1 degradation through distinct subcellular localization and E3 ligase interactions, affecting neural progenitor differentiation.

PLOS Biology · Jul 13, 2026Peer-reviewedCell Biology

Redox signaling regulates breast cancer metastasis via HIF1alpha-stimulated EMT dynamics and metabolic reprogramming

Z. Ren, M. Dharmaratne, H. Liang, O. Benard, M. Morales-Gallego, K. Suyama, A. T. Fard, J. C. Mar, M. Prystowsky, L. Norton, R. B. Hazan

This study shows that GPx2 loss in mammary tumors enhances metastasis through HIF1-driven EMT and metabolic changes, identified via scRNA-seq.

bioRxiv · Aug 29, 2022 · PreprintCancer Biology